Chemoinformaics analysis of Dihydrojavanicin Z
| Molecular Weight | 292.287 | nRot | 3 |
| Heavy Atom Molecular Weight | 276.159 | nRig | 12 |
| Exact Molecular Weight | 292.095 | nRing | 2 |
| Solubility: LogS | -2.355 | nHRing | 0 |
| Solubility: LogP | 2.069 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 40.5307 |
| nHD | 2 | BPOL | 20.3913 |
| QED | 0.645 |
| Synth | 2.751 |
| Natural Product Likeliness | 1.42 |
| NR-PPAR-gamma | 0.774 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.955 |
| HIA | 0.055 |
| CACO-2 | -5.055 |
| MDCK | 0.00000586 |
| BBB | 0.006 |
| PPB | 0.96953 |
| VDSS | 0.469 |
| FU | 0.0825925 |
| CYP1A2-inh | 0.494 |
| CYP1A2-sub | 0.962 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.128 |
| CYP2c9-inh | 0.231 |
| CYP2c9-sub | 0.806 |
| CYP2d6-inh | 0.082 |
| CYP2d6-sub | 0.292 |
| CYP3a4-inh | 0.066 |
| CYP3a4-sub | 0.191 |
| CL | 14.181 |
| T12 | 0.914 |
| hERG | 0.047 |
| Ames | 0.353 |
| ROA | 0.045 |
| SkinSen | 0.908 |
| Carcinogencity | 0.027 |
| EI | 0.901 |
| Respiratory | 0.06 |
| NR-Aromatase | 0.167 |
| Antiviral | Yes |
| Prediction | 0.802865 |